Literature DB >> 16741676

Pathognomonic genetic expression profile within peripheral blood mononuclear cells of rheumatic heart disease patients.

M Iqbal Baba1, Deepak Kaul, Anil Grover.   

Abstract

The present study was addressed to understand as to how the expression of genes, that play crucial role in both inflammation and autoimmune process, within blood mononuclear cells are effected by the molecular mimicry between streptococcal antigen and heart tissue recognized as main contributor towards the genesis of rheumatic heart disease (RHD). Such a study for the first time revealed that as compared to genomic profile within normal blood mononuclear cells, the cells derived from rheumatic heart disease patients exhibited significantly higher expression of genes coding for IL-8, IFN-gamma and CX3CR1 coupled with significant downregulation of CD36 mRNA expression. Based upon these results, we propose that maintenance of such a pathognomonic transcriptome within blood mononuclear cells may be responsible for the initiation and progression of rheumatic heart disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741676     DOI: 10.1007/s11010-006-9197-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

1.  TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages.

Authors:  G Draude; R L Lorenz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-04       Impact factor: 4.733

2.  Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages.

Authors:  T Nakagawa; S Nozaki; M Nishida; J M Yakub; Y Tomiyama; A Nakata; K Matsumoto; T Funahashi; K Kameda-Takemura; Y Kurata; S Yamashita; Y Matsuzawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-08       Impact factor: 8.311

3.  The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4delta2, IL-2, and IFNgamma in asthma.

Authors:  E M Glare; M Divjak; M J Bailey; E H Walters
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

4.  Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis.

Authors:  Toshihiro Nanki; Toshio Imai; Kenji Nagasaka; Yasuyo Urasaki; Yoshinori Nonomura; Ken Taniguchi; Kenji Hayashida; Jun Hasegawa; Osamu Yoshie; Nobuyuki Miyasaka
Journal:  Arthritis Rheum       Date:  2002-11

Review 5.  Cytokines in acute and chronic inflammation.

Authors:  C A Feghali; T M Wright
Journal:  Front Biosci       Date:  1997-01-01

Review 6.  Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.

Authors:  Giulia Chinetti-Gbaguidi; Jean-Charles Fruchart; Bart Staels
Journal:  Curr Opin Pharmacol       Date:  2005-04       Impact factor: 5.547

7.  How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease.

Authors:  K C Faé; S E Oshiro; A Toubert; D Charron; J Kalil; L Guilherme
Journal:  J Autoimmun       Date:  2005-03       Impact factor: 7.094

8.  Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions.

Authors:  Luiza Guilherme; Patricia Cury; Lea M F Demarchi; Verônica Coelho; Lúcia Abel; Ana P Lopez; Sandra Emiko Oshiro; Selma Aliotti; Edécio Cunha-Neto; Pablo M A Pomerantzeff; Ana C Tanaka; Jorge Kalil
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

9.  Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils.

Authors:  Shinji Higa; Toru Hirano; Mayumi Kotani; Motonobu Matsumoto; Akihito Fujita; Masaki Suemura; Ichiro Kawase; Toshio Tanaka
Journal:  J Allergy Clin Immunol       Date:  2003-06       Impact factor: 10.793

10.  Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia.

Authors:  D Xu; A Gruber; C Peterson; P Pisa
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.